Partnering with Biotechs to Scale Smarter from
Seed to Success
Unlock the Full Potential of Your Biotech
With decades of experience across the Life Sciences industry and a focus on biotech development, capital strategy, and clinical development execution, GLSA partners with biotechs to navigate their growth journey with precision, from funding through commercialization and exit.
GLSA Biotech delivers tailored strategies that integrate scientific innovation, capital efficiency, and operational execution to drive sustainable growth, strategic alignment, and long-term value for biotech companies and their investors.
Denise brings a hands-on, tailored approach to support your clinical development strategy, identifying cost-saving opportunities without compromising speed or quality empowering biotechs to achieve key milestones with greater efficiency and reduced financial risk.
Denise McNerney
Partner | Global Life Sciences Alliance
Trusted 30 Years in Accelerating Life Science Progress
- - - - - - -
See you at BIO Investor & Growth Summit | Save Our Sites | Venture Forum | DIA Annual Meeting | BIO International | Innovation Gathering
GLSA Biotech Solutions
Funding & Partnerships
Licensing & Co-Development Support
GLSA helps early-stage companies prepare for and connect with Investors and strategic partners by aligning development, business strategy, and execution for sustainable, long-term value creation.
-
Ensure readiness, compliance, and scalable operations
-
Plan licensing, partnerships, and co-development
-
Investor, strategic partner, and ecosystem introductions
Emerging Biotech Innovators
Building the Right Foundation
GLSA partners with seed and early-stage biotech's to translate innovation into viable development strategies, helping teams validate plans, control risk, and prepare for growth without overbuilding too soon.
-
Early scientific, preclinical, and clinical strategy alignment
-
Feasibility planning for right-sized development paths
-
Access to trusted advisors, vendors, and ecosystem partners
Clinical-Stage Execution
From First-in-Human to Expansion
GLSA supports clinical-stage startups and mid-stage biotech's with disciplined execution strategies that balance speed, cost control, and regulatory expectations as programs scale in complexity.
-
Streamlined study design and operational models
-
Site, vendor, and CRO selection to minimize risk and cost
-
Integrated clinical and operational planning
Preclinical Development
Strategy for Confident Progress
GLSA provides fractionalized preclinical leadership to align science, strategy, and execution.
- IND-enabling strategies and preclinical planning
- Asset prioritization and risk mitigation planning
- Alignment with regulatory and clinical objectives
Clinical Strategy Planning
Prepare for successful clinical trials
GLSA Solutions Team supports clear clinical strategies and study designs to reduce risk and align development.
- Protocol development and feasibility assessments
- Timeline, budget, and operational planning
- Alignment with regulatory and downstream requirements
Site Identification & Start up
Start with the right sites
Access GLSA’s pre-vetted global site networks and clinical research site community to ensure quality sites.
-
Site selection based on experience and patient access.
-
Ongoing site oversight and performance monitoring
-
Mitigate delays with proactive site support and training
Sign up to receive notifications and alerts for GLSA Investor Connections, including emerging opportunities and curated introductions.
Sign up to receive notifications and alerts for upcoming in-person and virtual GLSA / FOCM Networking Events to network with industry professionals.
Life Science Professionals can sign up to receive alerts for GLSA Accelerated Partnering. Curated, time-efficient spotlights to potential partners.
